Indian government dismissed media reports stating that Serum Institute India (SII) and Bharat Biotech’s emergency use authorisation EUA of COVID-19 vaccine was rejected and called it “fake news". Earlier the day, there was a rumour that SII and Bharat Biotech’s applications for emergency use of their vaccine have not been cleared yet due due to inadequate safety and efficacy data.
Indian government had clarified earlier that emergency use authorisation (EUA) for coronavirus vaccines developed by Hyderabad-based Bharat Biotech, Pune's Serum Institute of India and Pfizer were under consideration.“SII has applied for emergency use authorisation to DCGI. The application will be reviewed by the expert committee and after that final call will be taken,” a senior official of Ministry of Health and Family Welfare told reporters.
#FAKENEWS
The news running on @ndtvindia is Fake News. pic.twitter.com/VZv7uwW5z7
— Ministry of Health (@MoHFW_INDIA) December 9, 2020
All three vaccine makers have applied for EUA to the Drugs Controller General of India (DCGI). In India at least eight vaccines are in different stages of development in phase two and three clinical trials.
Pfizer, Serum Institute and Bharat Biotech applied for emergency use approval
